Asia Pacific Cell Counting Market Research Report- Forecast till 2027

Asia Pacific Cell Counting Market Information, By Instruments (Spectrophotometer, Cell Counter, Hemocytometer, Flow Cytometer, Hematology Analyzer, Microscope and others), By Application (Cell Structure Study and Cell Analysis, Quality Control, Cell Viability, Proliferation, Signaling, Identification, Single Cell Analysis and others) and End Users (Hospitals, Research Institutes, Pharmaceutical And Biotechnology Companies, Clinical Research Organizations and others) - Forecast till 2027

ID: MRFR/LS/0185-HCR | February 2021 | Region: Asia-Pacific | 60 pages

Asia Pacific Cell Counting Market Scenario


Cell counting is a type of method which is used for the counting or similar quantification of cells in the life sciences, including medical diagnosis and treatment of chronic diseases such as cancer. Increase in the number of White Blood Cells (WBC) may indicate the possibility of cancerous growth in the body. Cell counting is also important for researchers and it is one of the major steps in most experiments, which helps in maintaining cell cultures. It is an important procedure needed to be carried out before any analytical procedures and determine abnormal growth of cells. Furthermore, cell counting is an important step in many experiments done in microbiology, hematology and other medical specialties.


Drivers that increases the Asia Pacific cell counting market are emphasis of cell counting in the diagnosis and treatment of life threatening diseases such as cancer, along with a wide range of cell counting applications. For instance, according to American Cancer Society, nearly 1,688,780 new cases of cancer are expected in 2017 in the U.S., and about 600,920 deaths due to it. Furthermore, growing “out of pocket” expenditure and use of new technologies in cell counting led to market’s growth. However, high pricing of the advanced cell counting systems and lack of awareness among researchers to use advanced cell counting techniques are restraining the growth of Asia Pacific cell counting market to a certain extent.


The Asia Pacific cell counting market is expected to grow at a CAGR of approximately 10.5% during the forecast period from 2017-2023.

Figure 1: Market Synopsis of Cell Counting Market by Region, 2016 (%):


Asia Pacific Cell Counting Market--

Sources: National Institute of Standards & Technology, Small Business Innovation Research (SBIR), U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute Press Release, presentation, company website, annual reports, government records, journals expert interview


Segments


The Asia Pacific cell counting market is segmented on the basis on instruments used for cell counting which are spectrophotometer, cell counter, hemocytometer, flow cytometer, hematology analyzer, microscope and other instruments. On the basis of application of cell counting, cell structure study and cell analysis, quality control, cell viability, proliferation, signaling, identification, single cell analysis and other applications are includes. It is also segmented on the basis of its end users which are hospitals, research institutes, pharmaceutical and biotechnology companies, clinical research organizations and other end users.


Regional Analysis of Cell Counting Market


Asia Pacific cell counting market consists of countries namely China, Japan, Republic of Korea, India, Australia and rest of Asia Pacific. Increasing in number of diagnostic procedures for various chronic diseases and rising availability of cost effective diagnostic test drive the growth of the Asia Pacific cell counting market. Moreover, less complex regulations for drug development in Asian region has upsurged the growth of the Asia Pacific cell counting market.


Japan accounts the largest market share in Asia Pacific cell counting market in 2016. The growth of the Asia Pacific cell counting market is attributed to the development of medical devices in addition to research and development activities. Moreover, key market players are involved in the export of medical devices by focusing on developing markets to capture reasonable share in Asia Pacific cell counting market.


India is seen to be the fastest growing market for medical equipment manufactures. In India, the Asia Pacific cell counting market is increasing due to availability of low cost of raw material, better access to labor, increasing number of hospitals and healthcare centers. India is one of the top destinations for medical tourism, especially for orthopedic surgeries which is further influencing the market’s growth.


There is steady growth of this market in Australia and Republic of Korea during the forecast period from 2017-2023. 


Key Players for Cell Counting Market


Some of the key players in Asia Pacific cell counting market are Bio-Rad Laboratories Inc. (U.S), General Electric Company (U.S), Agilent Technologies (U.S), PerkinElmer Inc. (U.S), Tecan Trading AG (Switzerland), BioTek Instruments, Inc. (U.S), Danaher (U.S), and Merck KGaA (U.S), Thermo Fisher Scientific Inc. (U.S), among others .


Intended Audience



  • Research and development (R&D) companies

  • Medical research laboratories

  • Pharmaceutical companies

  • Biotechnology companies

  • Cell counting instruments manufacturers

  • Cell counting instruments suppliers

  • Academic medical institutes and universities


 



TOC

1. Report Prologue

2. Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators

5. Market Factor Analysis

5.1 Value Chain Analysis

5.2 Porter’s Five Forces

5.3 Demand & Supply: Gap Analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

5.6 Merger and Acquisition Landscape

5.7 Up-Coming Trends in Cell Counting Market

6. Asia Pacific Cell Counting Market by Instruments

6.1 Introduction

6.2 Spectrophotometer

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 Cell Counter

6.3.1 Market Estimates & Forecast, 2020-2027

6. 4 Hemocytometer

6.4.1 Market Estimates & Forecast, 2020-2027

6.5 low Cytometer

6.5.1 Market Estimates & Forecast, 2020-2027

6.6 Hematology Analyzer

6.6.1 Market Estimates & Forecast, 2020-2027

6.7 Microscope

6.7.1 Market Estimates & Forecast, 2020-2027

6.8 Others

7. Asia Pacific Cell Counting Market by Application

7.1 Introduction

7.2 Cell Structure Study and Cell Analysis

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Quality Control

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Cell Viability

7.4.1 Market Estimates & Forecast, 2020-2027

7.5 Proliferation

7.5.1 Market Estimates & Forecast, 2020-2027

7.6 Signaling

7.6.1 Market Estimates & Forecast, 2020-2027

7.7 Identification

7.7.1 Market Estimates & Forecast, 2020-2027

7.8 Single Cell Analysis

7.8.1 Market Estimates & Forecast, 2020-2027

7.9 Others

8. Asia Pacific Cell Counting Market by End Users

8.1 Introduction

8.2 Hospitals

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Research Institutes

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Biotechnology Companies

8.4.1 Market Estimates & Forecast, 2020-2027

8.5 Pharmaceutical Companies

8.5.1 Market Estimates & Forecast, 2020-2027

8.6 Others

9. Asia Pacific Cell Counting Market by Region

9.1 Introduction

9.2 Asia Pacific

9.2.1 Japan

9.2.2 China

9.2.3 India

9.2.4 Republic of Korea

9.2.5 Australia

9.2.6 Rest of Asia Pacific

10 Company Profile

10.1 Bio-Rad Laboratories Inc.

10.1.1 Overview

10.1.2 Product/Business Segment Overview

10.1.3 Financial Updates

10.1.4 Key Developments

10.2 General Electric Company

10.2.1 Overview

10.2.2 Product/Business Segment Overview

10.2.3 Financial Updates

10.2.4 Key Developments

10.3 Agilent Technologies

10.3.1 Overview

10.3.2 Product/Business Segment Overview

10.3.3 Financial Updates

10.3.4 Key Developments

10.4 Perkinelmer Inc.

10.4.1 Overview

10.4.2 Product/Business Segment Overview

10.4.3 Financial Updates

10.4.4 Key Developments

10.5 Tecan Trading AG

10.5.1 Overview

10.5.2 Product/Business Segment Overview

10.5.3 Financial Updates

10.5.4 Key Developments

10.6 Biotek Instruments, Inc.

10.6.1 Overview

10.6.2 Product/Business Segment Overview

10.6.3 Financial Updates

10.6.4 Key Developments

10.7 Merck KGaA

10.7.1 Company Overview

10.7.2 Product/Business Segment Overview

10.7.3 Financial Updates

10.7.4 Key Development

10.8 Danaher

10.8.1 Company Overview

10.8.2 Product/Business Segment Overview

10.8.3 Financial Updates

10.8.4 Key Development

11 Conclusion

11.1 Key Findings

11.1.1 From CEO`s Viewpoint

11.1.2 Unmet Needs of the Market

11.2 Key Companies to Watch

11.3 Prediction of Medical Device Industry

12 Appendix


LIST OF TABLES

Table 1 Cell Counting Industry Synopsis, 2020-2027

Table 2 Asia Pacific Cell Counting Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Asia Pacific Cell Counting Market by Region, 2020-2027, (USD Million)

Table 4 Asia Pacific Cell Counting Market by Instruments, 2020-2027, (USD Million)

Table 5 Asia Pacific Cell Counting Market by Application, 2020-2027, (USD Million)

Table 6 Asia Pacific Cell Counting Market by End Users, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Asia Pacific Cell Counting Market

Figure 3 Segmentation Market Dynamics for Asia Pacific Cell Counting Market

Figure 4 Asia Pacific Cell Counting Market Share, by Instruments 2020

Figure 5 Asia Pacific Cell Counting Market Share, by Application 2020

Figure 6 Asia Pacific Cell Counting Market Share, by End Users, 2020

Figure 10 Asia Pacific Hip Tendinitis Market Share, by Country, 2020

Figure 13 Agilent Technologies: Key Financials

Figure 14 Agilent Technologies: Segmental Revenue

Figure 15 Agilent Technologies: Geographical Revenue

Figure 16 Bio-Rad Laboratories Inc.: Key Financials

Figure 17 Bio-Rad Laboratories Inc.: Segmental Revenue

Figure 18 Bio-Rad Laboratories Inc.: Geographical Revenue

Figure 19 BioTek Instruments, Inc.: Key Financials

Figure 20 BioTek Instruments, Inc.: Segmental Revenue

Figure 21 BioTek Instruments, Inc.: Geographical Revenue

Figure 22 Danaher: Key Financials

Figure 23 Danaher: Segmental Revenue

Figure 24 Danaher: Geographical Revenue

Figure 25 Merck & Co., Inc.: Key Financials

Figure 26 Merck & Co., Inc.: Segmental Revenue

Figure 27 Merck & Co., Inc.: Geographical Revenue

Figure 28 General Electric Company: Key Financials

Figure 29 General Electric Company: Segmental Revenue

Figure 30 General Electric Company: Geographical Revenue

Figure 31 PerkinElmer Inc: Key Financials

Figure 32 PerkinElmer Inc: Segmental Revenue

Figure 33 PerkinElmer Inc: Geographical Revenue

Figure 34 Tecan Trading AG: Key Financials

Figure 35 Tecan Trading AG: Segmental Revenue

Figure 36 Tecan Trading AG: Geographical Revenue

Figure 37 Thermo Fisher Scientific Inc.: Key Financials

Figure 38 Thermo Fisher Scientific Inc.: Segmental Revenue

Figure 39 Thermo Fisher Scientific Inc.: Geographical Revenue